Full-dose blood thinners decreased need for life support and improved COVID outcomes
Full-dose anti-coagulation (blood thinner) treatments given to patients hospitalized for COVID-19 reduced the requirement of vital organ support in a large clinical trial conducted worldwide. With large numbers of COVID-19 ...
Jan 25, 2021
0
7